Choroid Plexus Neoplasm
NCI Definition: An intraventricular papillary neoplasm that originates from the choroid plexus epithelium. It includes the choroid plexus papilloma, atypical choroid plexus papilloma, and choroid plexus carcinoma. 
Choroid plexus neoplasms most frequently harbor alterations in TP53 .
TP53 c.217-c.1178 Missense, TP53 Mutation, and TP53 Missense are the most common alterations in choroid plexus neoplasm .
There is 1 clinical trial for choroid plexus neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains choroid plexus neoplasm as an inclusion criterion, 1 is no phase specified (1 open).
Standard of care is the most common intervention in choroid plexus neoplasm clinical trials.
Significant Genes in Choroid Plexus Neoplasm
MYCN is an inclusion eligibility criterion in 1 clinical trial for choroid plexus neoplasm, of which 1 is open and 0 are closed. Of the trial that contains MYCN status and choroid plexus neoplasm as inclusion criteria, 1 is no phase specified (1 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.